Business / Pharma
Evoke Pharma Secures Patent for GIMOTI, Extending Market Exclusivity
Evoke Pharma (NASDAQ: EVOK) has secured a patent for its GIMOTI® nasal spray, a treatment for gastroparesis. The U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance, extending market exclusivity to December 2036. This move...